Literature DB >> 27384739

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder?

Beatrice Benatti1, Giulia Camuri, Bernardo Dell'Osso, Laura Cremaschi, Ester Sembira, Carlotta Palazzo, Lucio Oldani, Cristina Dobrea, Chiara Arici, Diego Primavera, Bernardo Carpiniello, Filippo Castellano, Giuseppe Carrà, Massimo Clerici, David S Baldwin, Alfredo Carlo Altamura.   

Abstract

Anxiety disorders are common, comorbid, and disabling conditions, often underdiagnosed and under-treated, typically with an early onset, chronic course, and prolonged duration of untreated illness. The present study aimed to explore the influence of sociodemographic and clinical factors in relation to onset and latency to treatment in patients with generalized anxiety disorder (GAD), panic disorder (PD), and obsessive-compulsive disorder (OCD). A total of 157 patients with a Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision (DSM-IV-TR) diagnosis of PD (n=49), GAD (n=68), and OCD (n=40) were recruited, and epidemiological and clinical variables were collected through a specific questionnaire. Statistical analyses were carried out to compare variables across diagnostic groups. PD, GAD, and OCD patients showed a duration of untreated illness of 53.9±81.5, 77.47±95.76, and 90.6±112.1 months, respectively. Significant differences between groups were found with respect to age, age of first diagnosis, age of first treatment, family history of psychiatric illness, onset-related stressful events, benzodiazepine prescription as first treatment, antidepressant prescription as first treatment, and help-seeking (self-initiated vs. initiated by others). Patients with GAD, PD, and OCD showed significant differences in factors influencing onset and latency to treatment, which may, in turn, affect condition-related outcome and overall prognosis. Further studies with larger samples are warranted in the field.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27384739     DOI: 10.1097/YIC.0000000000000137

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  4 in total

1.  On the Development of OCD.

Authors:  T U Hauser
Journal:  Curr Top Behav Neurosci       Date:  2021

2.  The effect of the COVID-19 lockdown on mental health care use in South Africa: an interrupted time-series analysis.

Authors:  Anja Wettstein; Mpho Tlali; John A Joska; Morna Cornell; Veronika W Skrivankova; Soraya Seedat; Johannes P Mouton; Leigh L van den Heuvel; Nicola Maxwell; Mary-Ann Davies; Gary Maartens; Matthias Egger; Andreas D Haas
Journal:  Epidemiol Psychiatr Sci       Date:  2022-06-15       Impact factor: 7.818

3.  Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects.

Authors:  Marco Solmi; Michele Fornaro; Edoardo G Ostinelli; Caroline Zangani; Giovanni Croatto; Francesco Monaco; Damir Krinitski; Paolo Fusar-Poli; Christoph U Correll
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

4.  Adolescent Endorsement of the "Weak-Not-Sick" Stereotype for Generalised Anxiety Disorder: Associations with Prejudice, Discrimination, and Help-Giving Intentions toward Peers.

Authors:  Holly R Hanlon; Lorraine Swords
Journal:  Int J Environ Res Public Health       Date:  2020-07-28       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.